EGFR amplification and PI3K pathway mutations identify a subset of breast cancers that synergistically respond to EGFR and PI3K inhibition
David John Wisniewski, Donna M. Voeller, Yonit A. Addissie, Sachin Kumar Deshmukh, Sharon Wu, Maryam B. Lustberg, Darawalee Wangsa, Danny Wangsa, Kerstin Heselmeyer‐Haddad, Yoshimi Endo Greer, George W. Sledge, Stanley Lipkowitz
Oncogene · Nov 25, 2025Peer-reviewedCancer Biology